ARCHIVES

Rosenberg Starts New Study With TIL; LAK-IL-2 Costs Clarified

This article is from The Cancer Letter archive.

Vol. 12 No. 46 | November 28, 1986

Download PDF Visit The Full Archive

Related Articles

Amgen Says It Can Demonstrate Safety of Existing Hg Target.

March 16, 2007

Lynch Named Director, Yale Cancer Center

February 27, 2009

NIH Grantees Win Nobel Prizes In Medicine, Chemistry

October 9, 2009

NCI To Proceed With Guidelines Unless Board Strongly Disagree

May 9, 1980

Michael Friedman To Head PhRMA’s Office Of Biomedical Preparedness.

November 2, 2001

New Organ Systems Concept Flow Discussed

October 18, 1985